NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Temple Wearable Device Update

Deepinder Goyal, founder of Zomato and Swiggy, has generated interest online with a new teaser for his experimental wearable device, Temple. The announcement, shared on Instagram, provided minimal detail beyond a promotional image and a hint that the product will be made available to the public via a waitlist.

Key Features

The Temple device is designed to measure cerebral blood flow with high precision, monitoring tiny changes in oxygenation and circulation in the brain. This data can help researchers study how posture, activity, and lifestyle influence neurological health over time.

Read also: Kumar Mangalam Birla to Address Concluding Function of RSS Training Camp

Background

The concept of Temple was first introduced by Goyal in November 2025 as part of the "Gravity Ageing Hypothesis", which proposes that the constant pull of gravity may gradually reduce effective blood circulation to the brain, potentially linked to aspects of ageing and neurological health.

Current Status

Temple remains a prototype and is not yet commercially available. Goyal has clarified that no scientific data or public release has been issued, and he has advised observers not to treat the device as a consumer product at this stage.

Read also: The Cost of Healthcare: Why Predictability in Medical Inflation is Crucial for Health Insurance

Investor Takeaway

Zomato's founder is exploring new ventures in wearable technology, potentially expanding the company's ecosystem.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.